SOMAVERT 15 MG
PEGVISOMANT : 15 MG · DIN 02272202 · PFIZER CANADA ULC
Health Canada status: MARKETED
What is SOMAVERT?
SOMAVERT 15 MG contains PEGVISOMANT : 15 MG. It is listed in the Health Canada Drug Product Database under DIN 02272202, held by PFIZER CANADA ULC, supplied as POWDER FOR SOLUTION ; KIT for SUBCUTANEOUS administration. Health Canada currently lists it as marketed, status dated 24-Jan-2006. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is SOMAVERT used for?
SOMAVERT (pegvisomant for injection) is indicated for the treatment of acromegaly in patients who have had an inadequate response to surgery, and/or radiation therapy or for whom these therapies are not appropriate. The goal of treatment is to normalize serum insulin-like growth factor-I (IGF-I) levels and to improve clinical signs and symptoms.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02272202 |
|---|---|
| Brand name | SOMAVERT |
| Generic / active ingredient | PEGVISOMANT : 15 MG |
| Manufacturer | PFIZER CANADA ULC |
| Strength | 15 MG |
| Dosage form | POWDER FOR SOLUTION ; KIT |
| Route of administration | SUBCUTANEOUS |
| Schedule | Prescription |
| ATC code | H01AX01 PEGVISOMANT |
| AHFS class | 68:30.08 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 24-Jan-2006 |
| Original market date | 2006-01-24 00:00:00 |
How is it stored and handled?
null
How is it supplied?
1 or 30 vials
What can be used instead?
Other Canadian products sharing ATC code H01AX01 PEGVISOMANT. 5 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| SOMAVERT | 10 MG | POWDER FOR SOLUTION ; KIT | PFIZER CANADA ULC | MARKETED | DIN 02272199 |
| SOMAVERT | 20 MG | POWDER FOR SOLUTION ; KIT | PFIZER CANADA ULC | MARKETED | DIN 02272210 |
| SOMAVERT | 25 MG | POWDER FOR SOLUTION ; KIT | PFIZER CANADA ULC | MARKETED | DIN 02448831 |
| SOMAVERT | 30 MG | POWDER FOR SOLUTION ; KIT | PFIZER CANADA ULC | MARKETED | DIN 02448858 |
Who else supplies PEGVISOMANT worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PEGVISOMANT appears in 37 registered pack listings across 8 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.